AAPL354.17+22.27 (+6.71%) ▲|ABBV290.98+4.98 (+1.74%) ▲|ABT115.80+6.40 (+5.85%) ▲|ACN265.42+10.86 (+4.27%) ▲|ADBE248.70+2.56 (+1.04%) ▲|AMAT367.23-14.69 (-3.85%) ▼|AMD483.11-0.79 (-0.16%) ▼|AMGN479.06+17.80 (+3.86%) ▲|AMT192.97+5.68 (+3.03%) ▲|AMZN269.85+19.16 (+7.64%) ▲|AVGO328.55-3.58 (-1.08%) ▼|AXP331.91+6.41 (+1.97%) ▲|BA176.43+3.12 (+1.80%) ▲|BAC51.26+1.60 (+3.22%) ▲|BKNG172.66+16.99 (+10.91%) ▲|BLK1,226.83+65.51 (+5.64%) ▲|BMY63.17+1.46 (+2.37%) ▲|BNY151.80+2.49 (+1.67%) ▲|BRK-B573.67+16.60 (+2.98%) ▲|C124.67+1.96 (+1.59%) ▲|CAT583.28-40.66 (-6.52%) ▼|CL98.62+3.00 (+3.13%) ▲|CMCSA24.70+1.03 (+4.33%) ▲|COF206.73-1.98 (-0.95%) ▼|COP135.77-8.63 (-5.98%) ▼|COST1,047.09+27.83 (+2.73%) ▲|CRM226.38+4.18 (+1.88%) ▲|CSCO102.47-0.50 (-0.49%) ▼|CVS79.72-11.69 (-12.79%) ▼|CVX215.19-10.08 (-4.47%) ▼|DE674.85+9.02 (+1.35%) ▲|DHR234.53+4.42 (+1.92%) ▲|DIS119.67+5.49 (+4.81%) ▲|DUK129.58+3.07 (+2.43%) ▲|EMR171.29+4.90 (+2.94%) ▲|FDX324.63+6.61 (+2.08%) ▲|GD366.11-8.39 (-2.24%) ▼|GE331.92+11.25 (+3.51%) ▲|GEV817.75-100.46 (-10.94%) ▼|GILD174.38+6.91 (+4.13%) ▲|GM92.71+4.37 (+4.95%) ▲|GOOG290.38+12.11 (+4.35%) ▲|GOOGL291.98+11.95 (+4.27%) ▲|GS928.17+32.08 (+3.58%) ▲|HD351.94+18.28 (+5.48%) ▲|HON230.27+6.22 (+2.78%) ▲|IBM255.01+4.97 (+1.99%) ▲|INTC58.37-2.18 (-3.60%) ▼|INTU356.67+11.95 (+3.47%) ▲|ISRG484.97+44.22 (+10.03%) ▲|JNJ273.55+7.38 (+2.77%) ▲|JPM351.27+13.29 (+3.93%) ▲|KO95.91+1.11 (+1.17%) ▲|LIN525.83+14.28 (+2.79%) ▲|LLY1,421.57+12.19 (+0.86%) ▲|LMT595.60-43.40 (-6.79%) ▼|LOW228.04+14.66 (+6.87%) ▲|LRCX222.70-8.02 (-3.48%) ▼|MA668.15+20.97 (+3.24%) ▲|MCD278.17+15.13 (+5.75%) ▲|MDLZ67.74+2.62 (+4.02%) ▲|MDT105.06+6.18 (+6.24%) ▲|META635.97+14.94 (+2.41%) ▲|MMM194.30+17.25 (+9.74%) ▲|MO78.04+1.10 (+1.43%) ▲|MRK148.87+4.20 (+2.90%) ▲|MS192.83+6.74 (+3.62%) ▲|MSFT555.51+34.52 (+6.62%) ▲|MU807.80-47.30 (-5.53%) ▼|NEE88.53+4.20 (+4.98%) ▲|NFLX65.97+2.55 (+4.01%) ▲|NKE40.54+2.06 (+5.35%) ▲|NOW109.05-0.11 (-0.10%) ▼|NVDA203.89-2.80 (-1.35%) ▼|ORCL125.47-0.72 (-0.57%) ▼|PEP142.87+5.60 (+4.08%) ▲|PFE30.71+0.71 (+2.35%) ▲|PG167.12+5.06 (+3.12%) ▲|PLTR171.27-4.13 (-2.35%) ▼|PM210.67+2.64 (+1.27%) ▲|QCOM168.40+3.97 (+2.41%) ▲|RTX197.50-6.32 (-3.10%) ▼|SBUX108.51+3.74 (+3.57%) ▲|SCHW93.00+3.72 (+4.17%) ▲|SO93.23-0.52 (-0.55%) ▼|SPG227.90+5.82 (+2.62%) ▲|T21.79+0.40 (+1.85%) ▲|TMO706.09+7.75 (+1.11%) ▲|TMUS159.83+5.42 (+3.51%) ▲|TSLA389.00-9.50 (-2.38%) ▼|TXN311.09-1.41 (-0.45%) ▼|UBER71.47+4.87 (+7.31%) ▲|UNH408.87+4.43 (+1.09%) ▲|UNP307.94+4.51 (+1.48%) ▲|UPS114.06+4.89 (+4.47%) ▲|USB60.78+0.89 (+1.49%) ▲|V432.14+11.72 (+2.79%) ▲|VZ46.09+0.85 (+1.88%) ▲|WFC86.82+1.29 (+1.50%) ▲|WMT130.25+5.39 (+4.32%) ▲|XOM169.04-8.42 (-4.74%) ▼|AAPL354.17+22.27 (+6.71%) ▲|ABBV290.98+4.98 (+1.74%) ▲|ABT115.80+6.40 (+5.85%) ▲|ACN265.42+10.86 (+4.27%) ▲|ADBE248.70+2.56 (+1.04%) ▲|AMAT367.23-14.69 (-3.85%) ▼|AMD483.11-0.79 (-0.16%) ▼|AMGN479.06+17.80 (+3.86%) ▲|AMT192.97+5.68 (+3.03%) ▲|AMZN269.85+19.16 (+7.64%) ▲|AVGO328.55-3.58 (-1.08%) ▼|AXP331.91+6.41 (+1.97%) ▲|BA176.43+3.12 (+1.80%) ▲|BAC51.26+1.60 (+3.22%) ▲|BKNG172.66+16.99 (+10.91%) ▲|BLK1,226.83+65.51 (+5.64%) ▲|BMY63.17+1.46 (+2.37%) ▲|BNY151.80+2.49 (+1.67%) ▲|BRK-B573.67+16.60 (+2.98%) ▲|C124.67+1.96 (+1.59%) ▲|CAT583.28-40.66 (-6.52%) ▼|CL98.62+3.00 (+3.13%) ▲|CMCSA24.70+1.03 (+4.33%) ▲|COF206.73-1.98 (-0.95%) ▼|COP135.77-8.63 (-5.98%) ▼|COST1,047.09+27.83 (+2.73%) ▲|CRM226.38+4.18 (+1.88%) ▲|CSCO102.47-0.50 (-0.49%) ▼|CVS79.72-11.69 (-12.79%) ▼|CVX215.19-10.08 (-4.47%) ▼|DE674.85+9.02 (+1.35%) ▲|DHR234.53+4.42 (+1.92%) ▲|DIS119.67+5.49 (+4.81%) ▲|DUK129.58+3.07 (+2.43%) ▲|EMR171.29+4.90 (+2.94%) ▲|FDX324.63+6.61 (+2.08%) ▲|GD366.11-8.39 (-2.24%) ▼|GE331.92+11.25 (+3.51%) ▲|GEV817.75-100.46 (-10.94%) ▼|GILD174.38+6.91 (+4.13%) ▲|GM92.71+4.37 (+4.95%) ▲|GOOG290.38+12.11 (+4.35%) ▲|GOOGL291.98+11.95 (+4.27%) ▲|GS928.17+32.08 (+3.58%) ▲|HD351.94+18.28 (+5.48%) ▲|HON230.27+6.22 (+2.78%) ▲|IBM255.01+4.97 (+1.99%) ▲|INTC58.37-2.18 (-3.60%) ▼|INTU356.67+11.95 (+3.47%) ▲|ISRG484.97+44.22 (+10.03%) ▲|JNJ273.55+7.38 (+2.77%) ▲|JPM351.27+13.29 (+3.93%) ▲|KO95.91+1.11 (+1.17%) ▲|LIN525.83+14.28 (+2.79%) ▲|LLY1,421.57+12.19 (+0.86%) ▲|LMT595.60-43.40 (-6.79%) ▼|LOW228.04+14.66 (+6.87%) ▲|LRCX222.70-8.02 (-3.48%) ▼|MA668.15+20.97 (+3.24%) ▲|MCD278.17+15.13 (+5.75%) ▲|MDLZ67.74+2.62 (+4.02%) ▲|MDT105.06+6.18 (+6.24%) ▲|META635.97+14.94 (+2.41%) ▲|MMM194.30+17.25 (+9.74%) ▲|MO78.04+1.10 (+1.43%) ▲|MRK148.87+4.20 (+2.90%) ▲|MS192.83+6.74 (+3.62%) ▲|MSFT555.51+34.52 (+6.62%) ▲|MU807.80-47.30 (-5.53%) ▼|NEE88.53+4.20 (+4.98%) ▲|NFLX65.97+2.55 (+4.01%) ▲|NKE40.54+2.06 (+5.35%) ▲|NOW109.05-0.11 (-0.10%) ▼|NVDA203.89-2.80 (-1.35%) ▼|ORCL125.47-0.72 (-0.57%) ▼|PEP142.87+5.60 (+4.08%) ▲|PFE30.71+0.71 (+2.35%) ▲|PG167.12+5.06 (+3.12%) ▲|PLTR171.27-4.13 (-2.35%) ▼|PM210.67+2.64 (+1.27%) ▲|QCOM168.40+3.97 (+2.41%) ▲|RTX197.50-6.32 (-3.10%) ▼|SBUX108.51+3.74 (+3.57%) ▲|SCHW93.00+3.72 (+4.17%) ▲|SO93.23-0.52 (-0.55%) ▼|SPG227.90+5.82 (+2.62%) ▲|T21.79+0.40 (+1.85%) ▲|TMO706.09+7.75 (+1.11%) ▲|TMUS159.83+5.42 (+3.51%) ▲|TSLA389.00-9.50 (-2.38%) ▼|TXN311.09-1.41 (-0.45%) ▼|UBER71.47+4.87 (+7.31%) ▲|UNH408.87+4.43 (+1.09%) ▲|UNP307.94+4.51 (+1.48%) ▲|UPS114.06+4.89 (+4.47%) ▲|USB60.78+0.89 (+1.49%) ▲|V432.14+11.72 (+2.79%) ▲|VZ46.09+0.85 (+1.88%) ▲|WFC86.82+1.29 (+1.50%) ▲|WMT130.25+5.39 (+4.32%) ▲|XOM169.04-8.42 (-4.74%) ▼|
22.1 C
New York
Wednesday, November 4, 2026

Tag: press

newsFORsourcecompanycontentinformationreleases1market

AZI Announces Receipt of Minimum Bid Price Notice from Nasdaq

BEIJING, July 4, 2025 /PRNewswire/ -- Autozi Internet Technology (Global) Ltd. (Nasdaq: AZI) ("Autozi" or the "Company"), an automotive products and services company in...

NAIPO and MaxKare Light Up Walmart Deals Time July 8-13 with Unbeatable Discounts Up to 75% OFF!

Newark, N.J., July 4, 2025 /PRNewswire/ -- This July, Walmart Deals is back — and hotter than ever! From July 8 to 13, get...

The Week in Canadian Press Releases: 10 Stories You Need to See

A roundup of the most newsworthy press releases from Cision Distribution this week TORONTO, July 4, 2025 /CNW/ - With thousands of press releases published...

Little Pepe Raises Over $3,500,000 as It Becomes Ethereum’s Hottest Meme Token of 2025

DUBAI, United Arab Emirates, July 04, 2025 (GLOBE NEWSWIRE) -- Little Pepe has rapidly emerged as Ethereum’s hottest meme token of 2025, having raised over $3.5 million in its presale and currently in Stage 4 at a price of $0.0013. More than just a meme coin, Little Pepe combines viral appeal with real infrastructure, powered by a lightning-fast, low-cost Layer 2 EVM-compatible protocol designed for scalability and speed.

WIC briefs media on Digital Silk Road Development Forum

BEIJING, July 4, 2025 /PRNewswire/ -- A news report from CRI Online:   The World Internet Conference (WIC) held a press conference in Beijing on July 3...

Notified to Sponsor Third Annual ORY APAC-US Conference 2025 in Singapore

Notified announces its sponsorship of the third annual ORY APAC-US Conference 2025, taking place July 8-9, 2025 at Singapore.

TutorABC Launches ChatAI 1.0 Powered by TutorABC: Redefining Speaking Practice with AI Innovation

TAIPEI, July 4, 2025 /PRNewswire/ -- TutorABC, a global leader in online English and Chinese education, announces the launch of ChatAI 1.0 Powered by...

THEON accelerates strategic expansion in the Baltic Region

PRESS RELEASE

Miss Universe Guyana Appoints Ivonn Novikova as New Assistant Director

– Honouring the Legacy of Toni Burnett with Leadership and Vision – 
– Honouring the Legacy of Toni Burnett with Leadership and Vision –

Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist

Tokyo, Japan and Cambridge, UK, 4 July 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it will receive US$4.8 million in milestone payments from Centessa Pharmaceuticals pursuant to its research collaboration with Centessa. The milestones were achieved as Centessa initiated clinical development of ORX142, its second novel orexin receptor 2 (OX2R) agonist, following the recent clearance of an Investigational New Drug (IND) application by the US Food and Drug Administration (FDA) for a Phase 1 clinical study of ORX142 in healthy volunteers. (click here).

Invitation to presentation of Electrolux Group Q2 report

STOCKHOLM, July 4, 2025 /PRNewswire/ -- On 18th of July, Electrolux Group will publish the results for the second quarter of 2025, at approx. 07.00...

Invitation to presentation of Electrolux Group Q2 report

STOCKHOLM, July 4, 2025 /PRNewswire/ -- On 18th of July, Electrolux Group will publish the results for the second quarter of 2025, at approx. 07.00...

Invitation to presentation of Electrolux Group Q2 report

STOCKHOLM, July 4, 2025 /PRNewswire/ -- On 18th of July, Electrolux Group will publish the results for the second quarter of 2025, at approx. 07.00...

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer

PRESS RELEASE

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPress

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers